Search for other papers by C P Neves in
Google Scholar
PubMed
Search for other papers by E T Massolt in
Google Scholar
PubMed
Search for other papers by R P Peeters in
Google Scholar
PubMed
Search for other papers by S J Neggers in
Google Scholar
PubMed
Search for other papers by W W de Herder in
Google Scholar
PubMed
Summary
A 21-year-old woman presented with amenorrhea, bilateral galactorrhea and fatigue. Visual acuity and visual fields were normal. Laboratory examination demonstrated hyperprolactinemia. Magnetic resonance imaging (MRI) of the pituitary showed a 19×17×12-mm sellar mass with supra- and parasellar extension, causing compression of the pituitary stalk and optic chiasm. Further examinations confirmed mild hyperprolactinemia, strongly elevated TSH (>500 mU/l), low free thyroxine (FT4), hypogonadotropic hypogonadism and secondary adrenal insufficiency. Hydrocortisone and l-T4 replacement therapy was started. Three months later, the galactorrhea had disappeared, thyroid function was normalized and MRI revealed regression of the pituitary enlargement, confirming the diagnosis of pituitary hyperplasia (PH) due to primary hypothyroidism. Subsequently, the menstrual cycle returned and the hypocortisolism normalized. This case demonstrates that severe primary hypothyroidism may have an unusual presentation and should be considered in the differential diagnosis of pituitary enlargement associated with moderate hyperprolactinemia.
Learning points
-
One should always try to find one etiology as the common cause of all the clinical findings in a pathologic process.
-
Amenorrhea, galactorrhea and fatigue may be the only presenting clinical manifestations of primary hypothyroidism.
-
Not every patient with galactorrhea, hyperprolactinemia and a pituitary mass has a prolactinoma.
-
Primary hypothyroidism should always be considered in the differential diagnosis of hyperprolactinemia associated with pituitary enlargement and pituitary hormone(s) deficiency(ies).
-
When PH due to primary hypothyroidism is suspected, thyroid hormone replacement should be started and only regression of pituitary enlargement on MRI follow-up can confirm the diagnosis.
-
Examination of thyroid function in patients with a pituitary mass may avoid unnecessary surgery.
Search for other papers by M A W Hermans in
Google Scholar
PubMed
Search for other papers by B M L Stelten in
Google Scholar
PubMed
Search for other papers by H R Haak in
Google Scholar
PubMed
Search for other papers by W W de Herder in
Google Scholar
PubMed
Search for other papers by M W Dercksen in
Google Scholar
PubMed
Summary
This paper reports on two patients with a long-standing diagnosis of an ENETS stage IV neuroendocrine tumour (NET) of the small intestine who developed neurological symptoms. The first patient only had bulbar symptoms and tested positive for acetylcholine receptor antibodies. The second patient had more classical symptoms of fatigable diplopia and muscle weakness of the legs, but no detectable antibodies. The diagnosis of paraneoplastical myasthenia gravis (MG) was postulated. Both patients were treated with pyridostigmine for MG and octreotide for the NETs. Interestingly, treatment of the NETs resulted in improvement of myasthenic symptoms. Paraneoplastic MG has been described to occur with certain malignancies, mainly thymoma. Herein, we prove that the association with gastrointestinal NETs, however, rare, is also one to be considered by clinicians dealing with either of these diseases. The pathogenesis has yet to be elucidated.
Learning points
-
NETs are rare malignancies with a wide variety of symptoms.
-
Paraneoplastic MG can occur with various types of malignancies.
-
Herein, we provide evidence of paraneoplastic MG in association with a grade IV NET of the small intestine.
-
Treatment of the NETs resulted in remission of myasthenic symptoms in one patient.
Search for other papers by Eline van der Valk in
Google Scholar
PubMed
Search for other papers by Tom Tobe in
Google Scholar
PubMed
Search for other papers by Aline Stades in
Google Scholar
PubMed
Search for other papers by Alex Muller in
Google Scholar
PubMed
Summary
A 53-year-old male presented with recurrent calcium oxalate kidney stones as a first sign of underlying acromegaly, which vanished when his acromegaly was controlled. The exact mechanism behind hypercalciuria and urolithiasis in acromegaly is not yet clear. By discussing this case, a short overview of the pathophysiology of hypercalciuria in acromegaly and practical insights are given.
Learning points
-
Hypercalciuria is a common finding in acromegaly.
-
There are only few reports describing hypercalciuric kidney stones in acromegaly.
-
We assume that in acromegaly there is a primary role of IGF1-mediated, PTH-independent increase in calcitriol synthesis resulting in hypercalciuric kidney stones.
